Generex Biotechnology Corporation

GNBT · OTC
Analyze with AI
7/31/2020
7/31/2019
7/31/2018
7/31/2017
Operating Activities
Net Income-$34-$11$36-$77
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$10$11$1$1
Other Non-Cash$15-$13-$39$75
Operating Cash Flow-$6-$10-$2-$1
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions$0$2$0$0
Inv. Purchases$0$0$0-$4
Inv. Sales/Matur.$0$0$0$4
Other Inv. Act.$0$0-$0$0
Investing Cash Flow$0$2-$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$2,000$0$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$6$6,509$0$4
Financing Cash Flow$6$7$0$4
Forex Effect-$0-$0$0-$0
Net Chg. in Cash-$0-$1-$2$3
Supplemental Information
Beg. Cash$0$1$3$0
End Cash$0$0$1$3
Free Cash Flow-$6-$10-$2-$1